Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Bone Marrow Transplantation
|
September 6, 2023
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
N Worel, P Ljungman, I C M Verheggen, et al.
Annals of Hematology
|
December 22, 1999
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia
E Reiter, H T Greinix, F Keil, et al.
Bone Marrow Transplantation
|
November 15, 2011
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization
K Hübel, M M Fresen, J F Apperley, et al.
Bone Marrow Transplantation
|
March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA
K W Douglas, A N Parker, P J Hayden, et al.
Bone Marrow Transplantation
|
July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)
J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation
|
April 2, 2014
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
M Mohty, K Hübel, N Kröger, et al.
Bone Marrow Transplantation
|
December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
A Necchi, R Miceli, M Bregni, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Bone Marrow Transplantation
|
September 6, 2023
Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)
N Worel, P Ljungman, I C M Verheggen, et al.
Annals of Hematology
|
December 22, 1999
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia
E Reiter, H T Greinix, F Keil, et al.
Bone Marrow Transplantation
|
November 15, 2011
European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization
K Hübel, M M Fresen, J F Apperley, et al.
Bone Marrow Transplantation
|
March 2, 2011
Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA
K W Douglas, A N Parker, P J Hayden, et al.
Bone Marrow Transplantation
|
July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)
J P Halter, S M van Walraven, N Worel, et al.
Bone Marrow Transplantation
|
April 2, 2014
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
M Mohty, K Hübel, N Kröger, et al.
Bone Marrow Transplantation
|
December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
A Necchi, R Miceli, M Bregni, et al.
Page
of 4